Funding Details
- Awarder
- Inbox
- Date Award
- May 17, 2025
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
Company Info
- Traction
- The company intends to use the net proceeds from the offering for working capital, general corporate purposes, and expenses relating to the merger with Kadimastem Ltd.
- Company Description
- NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.
- Market
- Central Nervous System Disorders
- Location
-
Switzerland
Links